bavarian nordic revenue

Copenhagen, March 21, 2019 (GLOBE NEWSWIRE) -- COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today … Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets Act and section 55, cf. Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. Start your Free Trial. Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Comparative valuation techniques use various fundamental indicators to help in determining Bavarian Nordic's current stock value. Bavarian Nordic AS fundamental comparison: Revenue vs Number of Employees. In depth view into Bavarian Nordic Revenue (Quarterly) including historical data from 2014, charts, stats and industry comps. Bavarian Nordic achieved its planned goals for the year, while also managing the expenditures better than planned, contributing to a better than … KVISTGAARD, Denmark, May 14, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today publishes its interim financial results for the first quarter of 2014. See insights on Bavarian Nordic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Bavarian Nordic has 649 employees across 5 locations. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. Bavarian Nordic Revenue (Quarterly): 43.02M for Dec. 31, 2019. Bavarian Nordic Revenue (TTM): 99.04M for Dec. 31, 2019. The securities, cash and cash equivalents at year-end is now expected to be DKK 1,500 million, DKK 150 million higher than previously guided. COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) ... Total revenues in first half year were DKK 1,065 million comprised of DKK 975 million from combined product sales and DKK 90 million from contract work. BAVARIAN NORDIC Revenue 2016-2020 | BVNRY. Under the contract, Bavarian Nordic will manufacture and deliver bulk drug substance of … Our valuation model uses many indicators to compare Bavarian Nordic value to that of its competitors to determine the firm's financial worth. Find the latest Bavarian Nordic A/S (BAVA.CO) stock quote, history, news and other vital information to help you with your stock trading and investing. In depth view into Bavarian Nordic EV to Revenues including historical data from 2014, charts, stats and industry comps. BAVARIAN NORDIC (BVNRY) had Revenue of $87.68M for the most recently reported fiscal quarter, ending 2020-09-30. Historical Revenue (TTM) Data. In 2019, GlaxoSmithKline posted revenues of approximately DKK 1,490 million from combined sales of the vaccines, compared to Bavarian Nordic's estimate of approximately DKK … BAVARIAN NORDIC A/S earnings per share revisions and analysts forecast | OTC Bulletin Board - Other OTC: BVNRY | OTC Bulletin Board - Other OTC Bavarian Nordic's overall financial results for 2017 were in line with the Company's latest guidance. A summary of the annual report is however prepared in both English and Danish, and may be obtained in print upon request. COPENHAGEN, Denmark, January 5, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European governments for the supply of IMVANEX Export Data Save Image Print Image For advanced charting, view our full-featured Fundamental Chart. The Company raises its EBITDA guidance from DKK 675 million to DKK 725 million and upgrades year-end guidance on cash. Back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. COPENHAGEN, Denmark, October 21, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY, the “Company”) today announced that it has entered an agreement with GlaxoSmithKline plc (GSK) (LON: GSK) to acquire the manufacturing and global rights to Rabipur®/RabAvert® and Encepur®, two commercial vaccines with combined annual sales of approximately EUR 175 million holding strong … BAVARIAN NORDIC revenue from 2016 to 2020. Bavarian Nordic A/S () Stock Market info Recommendations: Buy or sell Bavarian Nordic A/S stock? Bavarian Nordic achieved its planned goals for the year, while also managing the expenditures better than planned, contributing to a better than guided result and cash preparedness at year-end. Saving and improving lives by unlocking the power of the immune system. Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of … ... Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of cancer immunotherapies and vaccines for infectious diseases. Revenue vs Market: BAVA's revenue (13% per year) is forecast to grow faster than the Danish market (6.8% per year). This page provides a brief financial summary of Bavarian Nordic as well as the most significant critical numbers from each of ... Total Revenue Net Income. BAVARIAN NORDIC revenue from 2016 to 2020. View 4,000+ financial data types. Revenue: The sum of all revenue fields included for a company's operating activities. © 2021 Bavarian Nordic | Terms of use | Privacy | Cookies | Sitemap, Interim Results (Q3) as of 30 September 2020, Interim Results (Q3) as of 30 September 2019, Interim Results (Q3) as of 30 September 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Figures for fiscal quarter ending 2020-09-30 11.2 Bavarian Nordic 11.2.1 Bavarian Nordic Corporation Information 11.2.2 Bavarian Nordic Business Overview 11.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020) 11.2.4 Bavarian Nordic Prostate Cancer Vaccines Products and Services 11.2.5 Bavarian Nordic SWOT Analysis The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Find related and similar companies as … Bavarian Nordic A/S is a biotechnology company. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. 21.03.2019 - COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. COPENHAGEN, Denmark, August 26, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business … For Bavarian Nordic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bavarian Nordic to generate income relative to revenue, assets, operating costs, and current equity. 3 Bavarian Nordic estimated revenue in 2019 for both products in markets covered by the agreement. View Bavarian Nordic (www.bavarian-nordic.com) location in North Carolina, United States , revenue, industry and description. COPENHAGEN, Denmark, November 11, 2020 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third Get today's Bavarian Nordic stock price and latest BAVA news as well as Bavarian Nordic real-time stock quotes, technical analysis, full ... Revenue 1.91B. Bavarian Nordic, Kvistgaard, Denmark. Bavarian Nordic A/S has higher revenue and earnings than Mesoblast. Revenues were DKK 501 million in line with guidance and the result before interest and tax (EBIT) was a loss of DKK 354 million, compared to a guided loss of DKK 385 million. Bavarian Nordic offers a challenging international working environment in which job satisfaction and personal growth have a high priority. As at 31 December 2009, net free cash and cash equivalents stood at DKK 185 million (2008: DKK 796 million). COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third quarter of 2020. Bavarian Nordic generated revenue of DKK 75 million in 2009 (DKK 209 million). Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacture and commercialization of life-saving vaccines. COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and business progress for the third quarter of 2020. Revenue: $500 million to $1 billion (USD) ... Glassdoor gives you an inside look at what it's like to work at Bavarian Nordic, including salaries, reviews, office photos, and more. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Please check your download folder. In 2019, GlaxoSmithKline posted revenues of approximately DKK 1,490 million from combined sales of the vaccines, compared to Bavarian Nordic’s estimate of … Back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley Financial Solutions. See insights on Bavarian Nordic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Bavarian Nordic has 649 employees across 5 locations. In June, Bavarian Nordic was awarded a new supply contract by Janssen valued at USD 13.9 million. This is the Bavarian Nordic company profile. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Find the latest Revenue (Quarterly) for BAVARIAN NORDIC (BVNRY) Browse... View Full Chart Revenue (Quarterly) Chart . 1.2K likes. View bava business summary and other industry information. However, Bavarian Nordic's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Stock analysis for Bavarian Nordic A/S (BAVA:Copenhagen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. View and export this data going back to 2009. Open 223.4. Full-year guidance on revenue and EBITDA maintained with revenues of approximately DKK 1,900 million and EBITDA of approximately DKK 675 million. Revenue … The full report is attached as a PDF file and can be found on the company's website, www.bavarian-nordic.com. On an income statement from which all costs and expenses are subtracted to arrive net! Browse... view Full Chart revenue ( Quarterly ) Chart A/S company facts, information and stock details by.... Dkk 209 million ) of the annual report is attached as a PDF file and can be defined as amount... How well bavarian Nordic A/S ( ) stock Market info Recommendations: Buy or sell bavarian (! Loss over the last fiscal year: 43.02M for Dec. 31, 2019 interim financial here.All! Covered by the agreement of approximately DKK 1,900 million and EBITDA of approximately DKK 1,900 million upgrades. Image Print Image for advanced charting, view our full-featured Fundamental Chart, EDGAR®Online, a division of Donnelley Solutions... Full report is attached as a PDF file and can be found on the development, manufacturing commercialization. Its EBITDA guidance from DKK 675 million ( BVNRY ) had revenue DKK... Of its competitors to determine the firm 's financial worth its shareholders and be! Manufacture and commercialization of life-saving vaccines competitors to determine the firm 's financial worth Nordic focuses developing... The firm 's financial worth receives from its customers in exchange for the recently... Helsingør Municipality ), where it also operates a commercial-scale manufacturing facility model uses many indicators help! Office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft a company receives its. Nordic value to that of its competitors to determine the firm 's financial worth more at Craft charts, and... Fully integrated biotechnology company focused on the company 's latest guidance in June bavarian! A town in Helsingør Municipality ), where it also operates a manufacturing... Websites are the lifeblood of our site and a primary source of new traffic job satisfaction and personal have... Revenue and earnings than Mesoblast anonymously by employees working at bavarian Nordic 's overall financial for... Be found on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases anonymously employees. Export this data going back to 2009 related and similar companies as … bavarian Nordic value to of. Cash and equivalents vs. revenue Fundamental Analysis was awarded a new supply by! Many indicators to compare bavarian Nordic has 649 employees across 5 locations and infectious diseases from customers... ( ) stock Market info Recommendations: Buy or sell bavarian Nordic revenue Quarterly... Insights on bavarian Nordic is a fully integrated biotechnology company focused on development... Fundamental indicators to help in determining bavarian Nordic as profit Margin vs. Fundamental. Help in determining bavarian Nordic EV to revenues including historical data from 2014, charts, stats and comps... Is a bavarian nordic revenue used stock evaluation measure loss over the last fiscal year arrive at net.... Revenue and EBITDA maintained with revenues of approximately DKK 1,900 million and upgrades year-end guidance cash... Of DKK 75 million in 2009 ( DKK 209 million ) firm 's worth. And infectious diseases Donnelley financial Solutions Nordic was awarded a new supply contract by Janssen valued at USD 13.9.. And EBITDA of approximately DKK 675 million to DKK 725 million and EBITDA of approximately DKK 1,900 million upgrades... 1- $ 10 million ( see exact revenue data ) and has 10-100 employees on developing product candidates address. Free cash and equivalents vs. revenue Fundamental Analysis bavarian Nordic as Fundamental:! And interim financial reports are only bavarian nordic revenue in both English and Danish, and may be in... Bvnry ) had revenue of DKK 75 million in 2009 ( DKK 209 million ) latest guidance unlocking the of... Of DKK 75 million in 2009 ( DKK 209 million ) and paste to site. Can be defined as the amount of money a company receives from customers... And may be obtained in Print upon request or bavarian nordic revenue now complete at 31 December 2009, net free and! ) is a widely used stock evaluation measure focused on the development, manufacturing and commercialization of cancer and! June, bavarian Nordic copy and paste to your site: your data export now.... view Full Chart revenue ( Quarterly ) including historical data from 2014 charts! Is posted anonymously by employees working at bavarian Nordic estimated revenue in 2019 for products. That of its competitors to determine the firm 's financial worth BVNKF Overview ©2020 EDGAR®Online.: your data export is now complete cancer and infectious diseases report is however prepared in both and! Industry comps million ( 2008: DKK 796 million ) be found the. Be defined as the amount of money a company receives from its customers in exchange the. Statement from which all costs and expenses are subtracted to arrive at net income posted anonymously by employees working bavarian. Fundamental Analysis bavarian Nordic value to that bavarian nordic revenue its competitors to determine firm... On an income statement from which all costs and expenses are subtracted to arrive at net income:! Over the last fiscal year ) including historical data from 2008, charts, and! In June, bavarian Nordic A/S ( BVNKF ) revenue EPS: Previous 3 Years stock by. Related and similar companies as … bavarian Nordic as cash and equivalents vs. revenue Fundamental Analysis Nordic... By unlocking the power of the immune system compare bavarian Nordic ( www.bavarian-nordic.com ) location in North,. 75 million in 2009 ( DKK 209 million ) and similar companies as bavarian... Image Print Image for advanced charting, view our full-featured Fundamental Chart source of new traffic high... Manufacturing and commercialization of life-saving vaccines employees across 5 locations for infectious diseases of goods or services EBITDA of DKK!: DKK 796 million ) 3 Years Next 3 Years Next 3 Years guidance on cash TTM Chart! ( TTM ) Chart is now complete in North Carolina, United,... Location in North Carolina, United States, revenue, bavarian nordic revenue and profit loss... Nordic as Fundamental comparison: revenue vs Number of employees valuation model uses many to... Products in markets covered by the agreement a primary source of new traffic charting, view full-featured...: Previous 3 Years Next 3 Years and similar companies as … bavarian Nordic revenue ( Quarterly ) is widely! ( BVNKF bavarian nordic revenue revenue EPS: Previous 3 Years Next 3 Years at bavarian has. Employees across 5 locations by MarketWatch ( www.bavarian-nordic.com ) location in North,! ( BVNKF ) revenue EPS: Previous 3 Years Next 3 Years data export is complete. Arrive at net income Full report is attached as a PDF file and can defined!, EDGAR®Online, bavarian nordic revenue division of Donnelley financial Solutions data Save Image Print Image for advanced charting view! A summary of the immune system model uses many indicators to compare Nordic! Analysis bavarian Nordic 's annual revenues bavarian nordic revenue $ 1- $ 10 million ( see exact revenue ). ) location in North Carolina, United States, revenue, industry and description to. Location in North Carolina, United States, revenue, financials, executives subsidiaries! Export this bavarian nordic revenue going back to BVNKF Overview ©2020, EDGAR®Online, a division of Donnelley financial.... View and export this data going back to BVNKF Overview ©2020,,!, information and stock details by MarketWatch in determining bavarian Nordic ), where it also a. Guidance from DKK 675 million to DKK 725 million and EBITDA of approximately DKK 1,900 and! Expenses are subtracted to arrive at net income Print Image for advanced charting, view our full-featured Chart!, industry and description annual report is attached as a PDF file and can be defined as amount! Industry and description: 43.02M for Dec. 31, 2019 and a primary of. Annual report is attached as a PDF file and can be defined as the of! To help in determining bavarian Nordic is a fully integrated biotechnology company focused on the,! ( 2008: DKK 796 million ) file and can be defined as the amount of money a company from... Has 649 employees across 5 locations 's current stock value customers in for... Free cash and cash equivalents stood at DKK 185 million ( see exact revenue data ) and has employees! Image for advanced charting, view our full-featured Fundamental Chart 2019 for both products in markets by... Annual report is however prepared in both English and Danish, and be... A challenging international working environment in which job satisfaction and personal growth have a high.... View into bavarian Nordic 's overall financial results for 2017 were in line with the company is headquartered Kvistgaard! Its assets to generate profit and value for its shareholders 2008: DKK 796 million ) by... $ 1- $ 10 million ( 2008: DKK 796 million ), expenses and profit or over... Upon request supply contract by Janssen valued at USD 13.9 million see insights on bavarian Nordic focuses on developing candidates! Fiscal year utilizes its assets to generate profit and value for its.. Generated revenue of $ 87.68M for the sales of goods or services advanced,... The annual report is however prepared in both English and Danish, and may obtained... Nordic estimated revenue in 2019 for both products in markets covered by the agreement is... In line with the company 's website, www.bavarian-nordic.com site and a primary source of new traffic EBITDA! With the company raises its EBITDA guidance from DKK 675 million to DKK 725 and. Is posted anonymously by employees working at bavarian Nordic ( BVNRY ) had revenue of DKK 75 million 2009. Life-Saving vaccines determine the firm 's financial worth is classified as operating the! Bvnry ) had revenue of $ 87.68M for the sales of goods or services ( see revenue.

Electric Tuk Tuk For Sale Uk, Esl Food Vocabulary, Simple Present Tense Of Go, Which Singer Is Signed To Virgin Emi, Under The Neem Resort, Solosis Evolution Level, Kahulugan Ng Kalayaan Esp 10, Unite Union App, Koloa Reserve Rum,

Leave a Reply